About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Expands License Agreement for Diclofenac Gel

May 18, 2016

Click here to read more

Post navigation

Phosphagenics Signs Japanese License Option Agreement for TPM Oxycodone Patch

Retirement of Non-Executive Director

Related Posts

Phosphagenics Participation in ‘New Innovations in Drug Delivery Technology’ Webcast

April 12, 2017

MEDIA | Australian Manufacturing Forum

March 3, 2025March 24, 2025

Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan

January 31, 2017

Recent Posts

New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025
Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.